This study retrospectively analyzed the United States Surveillance, Epidemiology, and End Results (SEER) Database. We found that the use of chemotherapy is associated with better outcome in patients with non-metastatic small-cell neuroendocrine carcinoma of the bladder. We also found that patients with T2 disease treated with surgery show better survival compared with those treated with radiotherapy.
- Neuroendocrine bladder cancer
- Prognostic variables
- Small-cell bladder cancer
ASJC Scopus subject areas